The United Kingdom on Wednesday indefinitely banned new prescriptions of puberty blockers to treat minors for gender dysphoria. The announcement comes a week after the U.S. Supreme Court heard oral arguments in a case involving state bans on puberty-suppressing medication and other forms of transition-related care for minors. Puberty blockers are commonly prescribed to transgender children in countries throughout the Western world to delay the onset of puberty or pause it as it is transpiring. A temporary ban on new puberty-blocker prescriptions for British minors experiencing gender dysphoria was already put in place over the summer. The U.K. ban comes as the U.S. Supreme Court weighs the constitutionality of a Tennessee ban on gender-affirming care for minors.

---

Persons: Wes Streeting, Dr, Hilary Cass, Cass, ”, ” Iris Duane, “ Organizations: U.S, Supreme, England’s National Health Service, Health, Social, Human Medicines, Labour, Britain’s Locations: Kingdom, Britain, Tennessee, U.S